Literature DB >> 31703536

Cyclooxygenase-2 modulates ER-mitochondria crosstalk to mediate superparamagnetic iron oxide nanoparticles induced hepatotoxicity: an in vitro and in vivo study.

Lin Che1, Huan Yao1, Chuan-Li Yang1, Ni-Jun Guo1, Jing Huang1, Zi-Li Wu1, Li-Yin Zhang1, Yuan-Yuan Chen1, Gang Liu1, Zhong-Ning Lin1, Yu-Chun Lin1.   

Abstract

Mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs) are central microdomains of the ER that interact with mitochondria. MAMs provide an essential platform for crosstalk between the ER and mitochondria and play a critical role in the local transfer of calcium (Ca2+) to maintain cellular functions. Despite the potential uses of superparamagnetic iron oxide nanoparticles (SPIO-NPs) in biomedical applications, the hepatotoxicity of these nanoparticles (NPs) is not well characterized and little is known about the involvement of MAMs in ER-mitochondria crosstalk. We studied SPIO-NPs-associated hepatotoxicity in vitro and in vivo. In vitro, human normal hepatic L02 cells were exposed to SPIO-NPs (2.5, 7.5, and 12.5 μg/mL) for 6 h and SPIO-NPs (12.5 μg/mL) was found to induce apoptosis. In vivo, SPIO-NPs induced liver injury when mice were intravenously injected with 20 mg/kg body weight SPIO-NPs for 24 h. Based on both in vitro and in vivo studies, we found that the structure and Ca2+ transport function of MAMs were perturbated and an accumulation of cyclooxygenase-2 (COX-2) in MAMs fractions was increased upon treatment of SPIO-NPs. The interaction between COX-2 and the components of MAMs, in terms of IP3R-GRP75-VDAC1 complex, was also revealed. Furthermore, the role of COX-2 in SPIO-NPs-associated hepatotoxicity was investigated by modifying the expression of COX-2. We demonstrated that COX-2 increases the structural and functional ER-mitochondria coupling and enhances the efficacy of ER-mitochondria Ca2+ transfer through the MAMs, thus sensitizing hepatocytes to a mitochondrial Ca2+ overload-dependent apoptosis. Taken together, our findings link SPIO-NPs-triggered hepatotoxicity with ER-mitochondria Ca2+ crosstalk which is mediated by COX-2 and provide mechanistic insight into the impact of interorganelle ER-mitochondria communication on hepatic nanotoxicity.

Entities:  

Keywords:  Superparamagnetic iron oxide nanoparticles; cyclooxygenase-2; hepatotoxicity; interorganelle Ca2+ transfer; mitochondria-associated endoplasmic reticulum membranes

Mesh:

Substances:

Year:  2019        PMID: 31703536     DOI: 10.1080/17435390.2019.1683245

Source DB:  PubMed          Journal:  Nanotoxicology        ISSN: 1743-5390            Impact factor:   5.913


  4 in total

1.  The Surface Amine Group of Ultrasmall Magnetic Iron Oxide Nanoparticles Produce Analgesia in the Spinal Cord and Decrease Long-Term Potentiation.

Authors:  Guan-Ling Lu; Ya-Chi Lin; Ping-Ching Wu; Yen-Chin Liu
Journal:  Pharmaceutics       Date:  2022-02-06       Impact factor: 6.321

2.  Green preparation of anti-inflammation an injectable 3D porous hydrogel for speeding up deep second-degree scald wound healing.

Authors:  Xiao Xu; Lin Che; Lin Xu; Doudou Huang; Jiashen Wu; Zebang Du; Yuchun Lin; Xiaoqian Hu; Qingliang Zhao; Zhongning Lin; Ling Xu
Journal:  RSC Adv       Date:  2020-09-30       Impact factor: 4.036

3.  Gut dysbacteriosis attenuates resistance to Mycobacterium bovis infection by decreasing cyclooxygenase 2 to inhibit endoplasmic reticulum stress.

Authors:  Haoran Wang; Jiao Yao; Yulan Chen; Yuanzhi Wang; Yiduo Liu; Yi Liao; Zhengmin Liang; Yu Hui Dong; Mengjin Qu; Xin Ge; Xiangmei Zhou
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

4.  Hepatocyte-Derived Prostaglandin E2-Modulated Macrophage M1-Type Polarization via mTOR-NPC1 Axis-Regulated Cholesterol Transport from Lysosomes to the Endoplasmic Reticulum in Hepatitis B Virus x Protein-Related Nonalcoholic Steatohepatitis.

Authors:  You Lan; Bo Qian; Hai-Yan Huang; Pan Wang; Ting Li; Qi Yuan; Han-Yu Zhang; Yu-Chun Lin; Zhong-Ning Lin
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.